Prot #REL-1017-302: A Phase 3, Multicenter, Randomized, Double-Blind, PlaceboControlled Study to Assess the Efficacy and Safety of REL-1017 for Major Depressive Disorder (The RELIANCE-II Study)

Project: Research project

Project Details

StatusActive
Effective start/end date9/23/24 → 9/23/27

Funding

  • Relmada Therapeutics, Inc. (Prot #REL-1017-302)